Avecho Biotechnology Limited (AVE)

Overview

Avecho Biotechnology Limited is a distinguished biotechnology firm rooted in Clayton, Australia, focusing on the invention and market introduction of products beneficial for both human and animal health. Utilizing its unique drug delivery system alongside Tocopherol Phosphate Mixture (TPM), the company excels in the biotechnology sector. Established in 1992, Avecho operates across two main segments: Production and Human Health, underscoring its versatility and commitment to improving health outcomes. Through strategic collaborations, such as with the Lambert Initiative at the University of Sydney for osteoarthritis treatment, Avecho underscores its devotion to advancing medical research and delivering innovative health solutions.

Products and Services

• TPM and Vital ET Products:

A cornerstone of Avecho's product lineup, TPM (Tocopherol Phosphate Mixture) and Vital ET products are designed for drug delivery and cosmetic formulations. These products leverage Avecho's proprietary delivery system to enhance the effectiveness and stability of active ingredients, offering advancements in topical and systemic therapeutics and in cosmetic applications.

• Human Health Portfolio:

This portfolio features a variety of delivery mechanisms for pharmaceutical products, including gels, injectables, and patches. Aimed at improving patient outcomes and experience, these delivery systems are developed to ensure precise dosing, enhance drug absorption, and provide user-friendly applications for medications, addressing a range of health conditions.

• Feed Additive Products:

With an eye on the agricultural sector, Avecho is also developing feed additive products intended to boost feed efficiency and the overall health of livestock animals. These innovations underscore the company's commitment to contributing towards sustainable livestock management by enhancing nutritional intake and promoting healthier livestock, which is vital for the agriculture industry.